clinical trial · NCT06143514
A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk
Relapsing Multiple SclerosisNo intervention
brief summary
The primary objective of the lactation study is to characterize the presence and concentration of BRIUMVI™ in breast milk among breastfeeding participants who receive BRIUMVI™ therapeutically for the treatment of relapsing forms of multiple sclerosis (RMS).
started
Mar 26, 2024
primary completion
Jun 30, 2026
completion
Jun 30, 2026
last updated
Apr 7, 2026
official title
A Post-marketing Study Evaluating the Presence and Concentration of BRIUMVI™ in Breast Milk (PROVIDE)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol